Inflammatory effects of phthalates in neonatal neutrophils

Pediatric Research

Volumn 68, Issue 2, 2010, Pages 134-139

  Vetrano, Anna M ^a   Laskin, Debra L ^b   Archer, Faith ^a   Syed, Kirin ^a   Gray, Joshua P ^c   Laskin, Jeffrey D ^a   Nwebube, Nkiru ^a   Weinberger, Barry ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c U S COAST GUARD ACADEMY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 8; MONO (2 ETHYLHEXYL) PHTHALATE; PHTHALIC ACID; RANTES; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; TROGLITAZONE; UNCLASSIFIED DRUG; VASCULOTROPIN; HYDROGEN PEROXIDE; MONO-(2-ETHYLHEXYL)PHTHALATE; OXIDIZING AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PHTHALIC ACID DERIVATIVE; PLASTICIZER;

AEROBIC METABOLISM; APOPTOSIS; ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUTROPHIL COUNT; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ADULT; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; DRUG EFFECTS; IMMUNOLOGY; INFLAMMATION; METABOLISM; NEUTROPHIL; NEWBORN; SIGNAL TRANSDUCTION;

ADULT; APOPTOSIS; CHEMOTAXIS; DIETHYLHEXYL PHTHALATE; HUMANS; HYDROGEN PEROXIDE; INFANT, NEWBORN; INFLAMMATION; NEUTROPHILS; OXIDANTS; PHTHALIC ACIDS; PLASTICIZERS; PPAR GAMMA; SIGNAL TRANSDUCTION;

EID: 77955159261     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181e5c1f7     Document Type: Article

References (55)

1. Kambia K, Dine T, Gressier B, Bah S, Germe AF, Luyckx M, Brunet C, Michaud L, Gottrand F 2003 Evaluation of childhood exposure to di(2-ethylhexyl) phthalate from perfusion kits during long-term parenteral nutrition. Int. J Pharm 262:83-91
2. Loff S, Subotic U, Reinicke F, Wischmann H, Brade J 2004 Extraction of di-ethylhexyl-phthalate from perfusion lines of various material, length and brand by lipid emulsions. J Pediatr Gastroenterol Nutr 39:341-345
3. Calafat AM, Needham LL, Silva MJ, Lambert G 2004 Exposure to di-(2-ethylhexyl) phthalate among premature neonates in a neonatal Int.ensive care unit. Pediatrics 113:e429-e434
4. Stroheker T, Cabaton N, Nourdin G, Regnier JF, Lhuguenot JC, Chagnon MC 2005 Evaluation of anti-androgenic activity of di-(2-ethylhexyl)phthalate. Toxicology 208:115-121
5. Kavlock R, Barr D, Boekelheide K, Breslin W, Breysse P, Chapin R, Gaido K, Hodgson E, Marcus M, Shea K, Williams P 2006 NTP-CERHR expert panel update on the reproductive and developmental toxicity of di(2-ethylhexyl) phthalate. Re-prod Toxicol 22:291-399
6. Parks LG, Ostby JS, Lambright CR, Abbott BD, Klinefelter GR, Barlow NJ, Gray LE Jr 2000 The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicol Sci 58:339-349
7. Moore RW, Rudy TA, Lin TM, Ko K, Peterson RE 2001 Abnormalities of sexual development in male rats with in utero and lactational exposure to the antiandrogenic plasticizer Di(2-ethylhexyl) phthalate. Environ Health Perspect 109:229-237
8. Gray LE Jr, Ostby J, Furr J, Price M, Veeramachaneni DN, Parks L 2000 Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. Toxicol Sci 58:350-365
9. Agarwal DK, Eustis S, Lamb JC, Reel JR, Kluwe WM 1986 Effects of di(2-ethylhexyl) phthalate on the gonadal pathophysiology, sperm morphology, and reproductive performance of male rats. Environ Health Perspect 65:343-350
10. Gourlay T, Samartzis I, Stefanou D, Taylor K 2003 Inflammatory response of rat and human neutrophils exposed to di-(2-ethyl-hexyl)-phthalate-plasticized polyvinyl chloride. Artif Organs 27:256-260
11. Calo L, Fracasso A, Cantaro S, Cozzi E, De Silvestro G, Plebani M, Bazzato G, Borsatti 1993 A Plasticizers induced mononuclear cells Int.erleukin 1 production: implications with peritoneal sclerosis. Clin Nephrol 40:57
12. Bally MB, Opheim DJ, Shertzer HG 1980 Di-(2-ethylhexyl) phthalate enhances the release of lysosomal enzymes from alveolar macrophages during phagocytosis. Toxicology 18:49-60
13. Latini G, De Felice C, Presta G, Del Vecchio A, Paris I, Ruggieri F, Mazzeo P 2003 In utero exposure to di-(2-ethylhexyl)phthalate and duration of human pregnancy. Environ Health Perspect 111:1783-1785
14. Hanna N, Vasquez P, Pham P, Heck DE, Laskin JD, Laskin DL, Weinberger B 2005 Mechanisms underlying reduced apoptosis in neonatal neutrophils. Pediatr Res 57:56-62
15. Calafat AM, McKee RH 2006 Int.egrating biomonitoring exposure data Int.o the risk assessment process: phthalates [diethyl phthalate and di(2-ethylhexyl) phthalate] as a case study. Environ Health Perspect 114:1783-1789
16. United States Food and Drug Administration Safety Assessment of Di(2-ethylhexyl) Phthalate (DEHP) Released from PVC Medical Devices. Available at: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/ Guidance Documents/UCM080457.pdf. Accessed March 16, 2010
17. Shea KM 2003 Pediatric exposure and potential toxicity of phthalate plasticizers. Pediatrics 111:1467-1474
18. Weinberger B, Vetrano AM, Syed K, Murthy S, Hanna N, Laskin JD, Laskin DL 2007 Influence of labor on neonatal neutrophil apoptosis, and inflammatory activity. Pediatr Res 61:572-577
19. Ferrante A, Thong YH 1980 Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leucocytes from human blood by the Hypaque-Ficoll method. J Immunol Methods 36:109-117
20. Boyden S 1962 The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med 115:453-466
21. Sgonc R, Gruber J 1998 Apoptosis detection: an overview. Exp Gerontol 33:525-533
22. Mohanty JG, Jaffe JS, Schulman ES, Raible DG 1997 A highly sensitive fluorescent micro-assay of H2O2 release from activated human leukocytes using a dihydroxy-phenoxazine derivative. J Immunol Methods 202:133-141
23. Hurst CH, Waxman DJ 2003 Activation of PPARalpha and PPARgamma by environmental phthalate monoesters. Toxicol Sci 74:297-308
24. Naito Y, Yoshikawa T 2004 Thiazolidinediones: a new class of drugs for the therapy of ischemia-reperfusion injury. Drugs Today (Barc) 40:423-430
25. Weinberger B, Laskin DL, Mariano TM, Sunil VR, DeCoste CJ, Heck DE, Gardner CR, Laskin JD 2001 Mechanisms underlying reduced responsiveness of neonatal neutrophils to distinct chemoattractants. J Leukoc Biol 70:969-976
26. Asikainen TM, White CW 2004 Pulmonary antioxidant defenses in the preterm newborn with respiratory distress and bronchopulmonary dysplasia in evolution: implications for antioxidant therapy. Antioxid Redox Signal 6:155-167
27. Kamrin MA 2009 Phthalate risks, phthalate regulation, and public health: a review. J Toxicol Environ Health B Crit Rev 12:157-174
28. Weisbach V, Koch HM, Angerer J, Eckstein R 2006 Di(2-ethylhexyl)phthalate exposure of apheresis donors is procedure-related. Transfusion 46:1457-1458, author reply 1459
29. Inoue K, Kawaguchi M, Yamanaka R, Higuchi T, Ito R, Saito K, Nakazawa H 2005 Evaluation and analysis of exposure levels of di(2-ethylhexyl) phthalate from blood bags. Clin Chim Acta 358:159-166
30. Latini G, Avery GB 1999 Materials degradation in endotracheal tubes: a potential contributor to bronchopulmonary dysplasia. Acta Paediatr 88:1174-1175
31. Silva MJ, Reidy JA, Preau JL, Samandar E, Needham LL, Calafat AM 2006 Measurement of eight urinary metabolites of di(2-ethylhexyl) phthalate as biomar-kers for human exposure assessment. Biomarkers 11:1-13
32. Plonait SL, Nau H, Maier RF, Wittfoht W, Obladen M 1993 Exposure of newborn infants to di-(2-ethylhexyl)-phthalate and 2-ethylhexanoic acid following exchange transfusion with polyvinylchloride catheters. Transfusion 33:598-605
33. Koch HM, Angerer J, Drexler H, Eckstein R, Weisbach V 2005 Di(2-ethylhexyl)phthalate (DEHP) exposure of voluntary plasma and platelet donors. Int. J Hyg Environ Health 208:489-498
34. Ljungvall K, Tienpont B, David F, Magnusson U, Torneke K 2004 Kinetics of orally administered di(2-ethylhexyl) phthalate and its metabolite, mono(2-ethylhexyl) phthalate, in male pigs. Arch Toxicol 78:384-389
35. Speer CP 2006 Pulmonary inflammation and bronchopulmonary dysplasia. J Peri-natol 26:S57-S62; discussion S63-64
36. Stefanutti G, Lister P, Smith VV, Peters MJ, Klein NJ, Pierro A, Eaton S 2005 P-selectin expression, neutrophil infiltration, and histologic injury in neonates with necrotizing enterocolitis. J Pediatr Surg 40:942-947; discussion 947-948
37. Scapini P, Lapinet-Vera JA, Gasperini S, Calzetti F, Bazzoni F, Cassatella MA 2000 The neutrophil as a cellular source of chemokines. Immunol Rev 177:195-203
38. Niggli V 2003 Signaling to migration in neutrophils: importance of localized pathways. Int. J Biochem Cell Biol 35:1619-1638
39. Abughali N, Berger M, Tosi MF 1994 Deficient total cell content of CR3 (CD11b) in neonatal neutrophils. Blood 83:1086-1092
40. Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, Choi AM 2007 Mechanisms of cell death in oxidative stress. Antioxid Redox Signal 9:49-89
41. Latini G 2000 Potential hazards of exposure to di-(2-ethylhexyl)- phthalate in babies. A review. Biol Neonate 78:269-276
42. Lambeth JD, Kawahara T, Diebold B 2007 Regulation of Nox and Duox enzymatic activity and expression. Free Radic Biol Med 43:319-331
43. Tsukimori K, Komatsu H, Yoshimura T, Hikino S, Hara T, Wake N, Nakano H 2007 Increased inflammatory markers are associated with early periventricular leukoma-lacia. Dev Med Child Neurol 49:587-590
44. Newburger PE 1982 Superoxide generation by human fetal granulocytes. Pediatr Res 16:373-376
45. Rosenfeld W, Concepcion L 1986 Endogenous antioxidant defenses in neonates. J Free Radic Biol Med 2:295-298
46. Carr R 2000 Neutrophil production and function in newborn infants. Br J Haematol 110:18-28
47. Baggiolini M, Loetscher P, Moser B 1995 Int.erleukin-8 and the chemokine family. Int. J Immunopharmacol 17:103-108
48. Kotecha S 1996 Cytokines in chronic lung disease of prematurity. Eur J Pediatr 155:S14-S17
49. Scaldaferri F, Vetrano S, Sans M, Arena V, Straface G, Stigliano E, Repici A, Sturm A, Malesci A, Panes J, Yla-Herttuala S, Fiocchi C, Danese S 2009 VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. Gas-troenterology 136:585-595
50. Chinetti G, Griglio S, Antonucci M, Torra IP, Delerive P, Majd Z, Fruchart JC, Chapman J, Najib J, Staels B 1998 Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem 273:25573-25580
51. Collin M, Patel NS, Dugo L, Thiemermann C 2004 Role of peroxisome proliferator-activated receptor-gamma in the protection afforded by 15-deoxydelta12,14 prosta-glandin J2 against the multiple organ failure caused by endotoxin. Crit Care Med 32:826-831
52. Kuhn H, O'Donnell VB 2006 Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res 45:334-356
53. Scher JU, Pillinger MH 2005 15d-PGJ2: the anti-inflammatory prostaglandin? Clin Immunol 114:100-109
54. Hillman LS, Goodwin SL, Sherman WR 1975 Identification and measurement of plasticizer in neonatal tissues after umbilical catheters and blood products. N Engl J Med 292:381-386
55. Roth B, Herkenrath P, Lehmann HJ, Ohles HD, Homig HJ, Benz-Bohm G, Kreuder J, Younossi-Hartenstein A 1988 Di-(2-ethylhexyl)-phthalate as plasticizer in PVC respiratory tubing systems: indications of hazardous effects on pulmonary function in mechanically ventilated, preterm infants. Eur J Pediatr 147:41-46